Immunohistochemistry tests in Dubai & UAE

Compare available Immunohistochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

450.00–3,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Immunohistochemistry test prices

Showing 46–60 of 89 matching tests.

Immunohistochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1857 Immunohistochemistry CDX-2 Test This diagnostic test evaluates the presence and localization of the CDX-2 nuclear protein within tissue samples.	FFPE tissue block or biopsy slides	5–7 business days	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDX-2 nuclear protein expression", "Tissue-based protein localization"] Parameters [] Preparation ["No special patient preparation required", "Provide copy of histopathology report", "Provide biopsy site details"] Indications ["Identification of gastrointestinal origin in metastatic adenocarcinomas", "Tumor classification", "Guiding site-specific therapy protocols"] Measurement technique Confirm with laboratory Codes LOINC: 94318-5 ICD-10: C18.9 Clinical summary This diagnostic test evaluates the presence and localization of the CDX-2 nuclear protein within tissue samples.
TEST-1776 Immunohistochemistry Comprehensive Panel Test This test evaluates archival tissue specimens (FFPE blocks) using immunohistochemistry to determine tumour characteristics and guide cancer therapy.	Archival Tissue Specimen (FFPE Block)	7 working days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Tumour lineage", "Tumour differentiation", "Predictive biomarkers", "Specific protein markers"] Parameters [] Preparation [] Indications ["Diagnosis of cancer subtype", "Guiding targeted cancer therapy", "Classification of carcinomas, sarcomas, lymphomas, and other malignancies"] Measurement technique Confirm with laboratory Codes LOINC: 19057-0 ICD-10: C80.1 Clinical summary This test evaluates archival tissue specimens (FFPE blocks) using immunohistochemistry to determine tumour characteristics and guide cancer therapy.
TEST-2006 Immunohistochemistry Cytokeratin-19 (CK-19) Test This diagnostic test evaluates tissue samples for the presence of the cytokeratin-19 protein, a marker commonly found in carcinomas.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Surgical Pathology Sections	5–7 business days	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Cytokeratin-19 protein expression"] Parameters [] Preparation [] Indications ["Determining tumor origin", "Identifying carcinomas", "Assisting in metastatic disease diagnosis", "Guiding oncologic management"] Measurement technique Confirm with laboratory Codes LOINC: 21970-7 ICD-10: C80.1 Clinical summary This diagnostic test evaluates tissue samples for the presence of the cytokeratin-19 protein, a marker commonly found in carcinomas.
TEST-1887 Immunohistochemistry Cytomegalovirus (CMV) Test This diagnostic test evaluates the presence of Cytomegalovirus (CMV) proteins within tumor tissue samples.	Formalin-fixed paraffin-embedded (FFPE) tumor tissue block or slides (Archival Tissue Specimen)	5–7 business days	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Cytomegalovirus (CMV) proteins"] Parameters [] Preparation ["Provide histopathology report", "Provide biopsy site details", "Provide clinical history"] Indications ["Oncologic pathology", "Assessment of viral presence in tumor tissue"] Measurement technique Confirm with laboratory Codes LOINC: 41956-6 ICD-10: B25.9 Clinical summary This diagnostic test evaluates the presence of Cytomegalovirus (CMV) proteins within tumor tissue samples.
TEST-1977 Immunohistochemistry D2-40 (Podoplanin) Test This diagnostic test evaluates formalin-fixed, paraffin-embedded (FFPE) tissue sections for the presence of podoplanin, a marker for lymphatic endothelial cells.	FFPE Tissue Block / Biopsy Slides (Archival Specimen)	5–7 Business Days	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Podoplanin expression", "Lymphatic endothelial cells"] Parameters [] Preparation ["Provide tissue sample (biopsy or surgical specimen) fixed in formalin", "Provide copy of histopathology report and clinical history"] Indications ["Diagnosis of lymphangiomas", "Diagnosis of Kaposi sarcoma", "Assessment of lymphovascular invasion in malignant neoplasms"] Measurement technique Confirm with laboratory Codes LOINC: 75174-1 ICD-10: D18.1, C46.9, C49.9 Clinical summary This diagnostic test evaluates formalin-fixed, paraffin-embedded (FFPE) tissue sections for the presence of podoplanin, a marker for lymphatic endothelial cells.
TEST-2009 Immunohistochemistry Desmin Test This diagnostic test evaluates the presence and expression level of the desmin protein within tumor tissue samples.	FFPE Tissue Block / Surgical Pathology Cuts	5-7 Business Days	450.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Desmin intermediate filament protein expression", "Myogenic differentiation"] Parameters [] Preparation ["Share full medication list, especially blood thinners"] Indications ["Diagnosis of myogenic sarcomas", "Differentiation of rhabdomyosarcoma", "Differentiation of leiomyosarcoma", "Guidance for targeted oncology treatment"] Measurement technique Confirm with laboratory Codes LOINC: 37438-5 ICD-10: C49.9 Clinical summary This diagnostic test evaluates the presence and expression level of the desmin protein within tumor tissue samples.
TEST-2013 Immunohistochemistry E-Cadherin (ECAD) Test This diagnostic test evaluates the expression of the E-Cadherin protein in tissue samples to aid in cancer diagnosis and risk assessment.	FFPE tissue block or biopsy slides (archival)	5–7 business days	450.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["E-Cadherin protein expression", "Protein loss in tissue"] Parameters [] Preparation ["No fasting required", "No medication changes needed"] Indications ["Differentiation of lobular vs. ductal breast carcinoma", "Identification of hereditary diffuse gastric cancer risk", "Assessment of protein loss in tissue"] Measurement technique Confirm with laboratory Codes LOINC: 21922-0 ICD-10: C50.9, C16.9 Clinical summary This diagnostic test evaluates the expression of the E-Cadherin protein in tissue samples to aid in cancer diagnosis and risk assessment.
TEST-2018 Immunohistochemistry FSH Test This diagnostic test evaluates the presence and expression level of Follicle Stimulating Hormone (FSH) protein within tumor tissue samples.	Archival Tissue Specimen (FFPE tissue block or fresh tumor in formalin)	5 business days (standard block), 7 business days (large complex cases)	450.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Follicle Stimulating Hormone (FSH) protein expression", "Tumor cellular characteristics"] Parameters [{"name": "FSH Expression", "reference_range": null}] Preparation ["No special patient preparation is needed.", "Clinician coordinates tumor tissue submission with complete histopathology report and clinical history."] Indications ["Diagnosis and classification of pituitary neoplasms", "Diagnosis and classification of ovarian neoplasms", "Diagnosis and classification of testicular neoplasms", "Distinguishing morphologically similar tumor subtypes"] Measurement technique Confirm with laboratory Codes LOINC: 30061-3 ICD-10: D35.2, C56.9, C62.90 Clinical summary This diagnostic test evaluates the presence and expression level of Follicle Stimulating Hormone (FSH) protein within tumor tissue samples.
TEST-2022 Immunohistochemistry GATA-3 Test This diagnostic test evaluates the presence and expression level of the GATA-3 protein in tumor tissue samples.	FFPE tissue block or biopsy tissue in 10% formalin	5–7 working days from specimen receipt	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GATA binding protein 3 expression"] Parameters [] Preparation ["Provide histopathology report", "Provide biopsy site details", "Provide clinical history"] Indications ["Classification of breast carcinoma", "Classification of urothelial carcinoma", "Distinguishing primary tumor origins"] Measurement technique Confirm with laboratory Codes LOINC: 104217-0 ICD-10: C50.9, C67.9 Clinical summary This diagnostic test evaluates the presence and expression level of the GATA-3 protein in tumor tissue samples.
TEST-1895 Immunohistochemistry Glial Fibrillary Acidic Protein (GFAP) Test This diagnostic test evaluates tumor tissue for the presence of glial fibrillary acidic protein (GFAP) to confirm astrocytic differentiation.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block / Archival Solid Tissue Specimen	5 Days (FFPE Block) / 5 Days (Tissue Biopsy) / 7 Days (Large Complex Tissue)	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Glial Fibrillary Acidic Protein (GFAP) expression", "Astrocytic differentiation"] Parameters [{"name": "GFAP Expression", "reference_range": "Positive/Negative"}] Preparation [] Indications ["Suspected primary brain tumor", "Differentiation of glial vs. non-glial CNS lesions", "Tumor subtyping for targeted therapy"] Measurement technique Confirm with laboratory Codes LOINC: 94474-4 ICD-10: C71.9 Clinical summary This diagnostic test evaluates tumor tissue for the presence of glial fibrillary acidic protein (GFAP) to confirm astrocytic differentiation.
TEST-1785 Immunohistochemistry Glycophorin A (GPA) Test This test identifies the presence of Glycophorin A protein in tissue samples to determine erythroid lineage.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Blocks or Slides	5 working days (blocks), 7 working days (complex tissue)	450.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Glycophorin A protein expression"] Parameters [] Preparation ["Submit formalin-fixed paraffin-embedded block or tissue in 10% neutral buffered formalin.", "Include histopathology report, biopsy site details, and clinical history."] Indications ["Diagnosis of acute myeloid leukemia", "Diagnosis of myelodysplastic syndromes", "Diagnosis of lymphoma", "Equivocal morphology for erythroid differentiation"] Measurement technique Confirm with laboratory Codes LOINC: 40876-0 ICD-10: C92.0, C94.0, D46.9 Clinical summary This test identifies the presence of Glycophorin A protein in tissue samples to determine erythroid lineage.
TEST-2032 Immunohistochemistry Glypican-3 (GPC3) Test This diagnostic test evaluates the presence and expression level of the Glypican-3 (GPC3) protein in tumor tissue samples.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block	5–7 Working Days	450.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Glypican-3 (GPC3) protein expression"] Parameters [] Preparation ["Provide original Histopathology report", "Provide exact site of biopsy", "Provide detailed clinical history"] Indications ["Suspicious liver mass identified on imaging", "Pathological diagnosis of hepatocellular carcinoma (HCC)", "Differential diagnosis of liver tumors"] Measurement technique Confirm with laboratory Codes LOINC: 94218-3 ICD-10: C22.0 Clinical summary This diagnostic test evaluates the presence and expression level of the Glypican-3 (GPC3) protein in tumor tissue samples.
TEST-2041 Immunohistochemistry Inhibin Test This test evaluates the presence and level of inhibin protein expression within tumor tissue samples.	FFPE Tissue Block / Biopsy Slides (Archival)	5–7 working days	450.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Inhibin protein expression", "Immunoreactivity in tumor tissue"] Parameters [] Preparation ["No special patient preparation required", "Ensure biopsy tissue is fixed in 10% formalin"] Indications ["Evaluation of ovarian sex cord-stromal tumors", "Evaluation of adrenal cortical neoplasms", "Differential diagnosis of inhibin-secreting malignancies"] Measurement technique Confirm with laboratory Codes LOINC: 94495-7 ICD-10: C56.9, D44.1 Clinical summary This test evaluates the presence and level of inhibin protein expression within tumor tissue samples.
TEST-2031 Immunohistochemistry Luteinizing Hormone (LH) Test This diagnostic test evaluates the expression of Luteinizing Hormone (LH) within tumor tissue samples.	Formalin-fixed paraffin-embedded (FFPE) tissue block or slides. Archival tissue specimen.	5–7 business days (block/tissue); daily processing until 6 PM	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Luteinizing Hormone (LH) protein expression", "Cellular localization of LH"] Parameters [] Preparation [] Indications ["Differentiation of neuroendocrine and reproductive neoplasms", "Guiding targeted therapy in pituitary adenomas", "Diagnosis of gonadal stromal tumors", "Evaluation of LH-secreting lesions"] Measurement technique Confirm with laboratory Codes LOINC: 69023-4 ICD-10: C75.1 Clinical summary This diagnostic test evaluates the expression of Luteinizing Hormone (LH) within tumor tissue samples.
TEST-1914 Immunohistochemistry Melan-A (MART-1) Test This test detects the presence of the Melan-A protein in tissue samples to help confirm a diagnosis of melanoma.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Block or Tissue Sections	5–7 days	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Melan-A protein expression", "Melanocytic lineage"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "85–97% (Superior for epithelioid melanoma)"}, {"name": "Methodology", "reference_range": "Automated IHC Platform with polymer-based detection"}, {"name": "Antibody Clone", "reference_range": "A103 / M2-7C10"}] Preparation ["No patient preparation required"] Indications ["Confirmation of melanoma diagnosis", "Differentiation from non-melanocytic malignancies", "Guiding targeted immunotherapy"] Measurement technique Confirm with laboratory Codes LOINC: 94836-4 ICD-10: C43.9 Clinical summary This test detects the presence of the Melan-A protein in tissue samples to help confirm a diagnosis of melanoma.

Category overview

Immunohistochemistry: overview

Achieving a definitive, targeted diagnosis for suspected malignancies or severe inflammatory conditions requires literally highlighting the disease markers hidden within your tissue. As a foundational diagnostic tool in our Histology department, Immunohistochemistry (IHC) utilizes specialized fluorescent or colored antibodies that bind directly to specific disease-related proteins in a biopsied sample. Utilizing cutting-edge microscopic technology, this vital cellular screening helps precisely classify tumors, detect hidden infections, and evaluate prognostic markers, providing the definitive data necessary to safely guide life-saving precision medicine, specialized oncology treatments, and proactive medical management. Consistently ranked among the premier diagnostic labs in the UAE for tissue analysis, DNA Labs guarantees strict patient confidentiality, exceptional diagnostic accuracy, and incredibly efficient reporting. Take an empowered step toward targeted treatment—book your immunohistochemistry testing in UAE, arrange a secure clinical sample collection, or connect with our dedicated medical specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.